Epinephrine: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==General== | |||
*Type: [[Vasopressors]] | |||
*Dosage Forms: | |||
*Common Trade Names: | |||
==Adult Dosing== | |||
==Pediatric Dosing== | |||
==Special Populations== | |||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: | |||
*Lactation: | |||
*Renal Dosing | |||
**Adult | |||
**Pediatric | |||
*Hepatic Dosing | |||
**Adult | |||
**Pediatric | |||
==Contraindications== | |||
*Allergy to class/drug | |||
==Adverse Reactions== | |||
===Serious=== | |||
===Common=== | |||
==Pharmacology== | |||
*Half-life: | |||
*Metabolism: | |||
*Excretion: | |||
*Mechanism of Action: | |||
==See Also== | |||
==Sources== | |||
<references/> | |||
[[Category:Drugs]] | |||
==Concentration== | ==Concentration== | ||
*Amount of solution in mL used to dilute 1,000mg of epinephrine | *Amount of solution in mL used to dilute 1,000mg of epinephrine | ||
Revision as of 14:35, 20 December 2014
General
- Type: Vasopressors
- Dosage Forms:
- Common Trade Names:
Adult Dosing
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
See Also
Sources
Concentration
- Amount of solution in mL used to dilute 1,000mg of epinephrine
- eg 1:10,000 = 1,000mg/10,000mL = 0.1mg/mL
Adult Dosing
Anaphylaxis
0.3-0.5mg of 1:1,000 IM
- Consider glucagon 1-5mg IV if pt on B-blockers and not responding to epi
Anaphylactic shock
0.1mg of 1:10,000 slow IV during 5 min, can start infusion of 1-4 mcg/min
Cardiac Arrest
1mg of 1:10,000 IVP
Pediatric Dosing
See critical care quick reference for drug doses by weight.
See Also
Pressor
Indication
- Anaphylaxis
Primary Receptor
- β1
- α1
- β2
Relative Effects
- ↑↑↑HR
- ↑↑↑SV
- ↑↑↑SVR
- Bronchodilation (β2)
Dosing
- Dose-dependent effects:
- 1-10 mcg/min - increase HR and SV
- 10-20 mcg/min - increase SVR
Rate of Titration
- Q2-5 min
Adverse Effects
- Tachyarrhythmias
- Myocardial ischemia
- ↑Serum lactate
- Splanchnic ischemia
Notes
- ↑lactate occurs primarily from ↑glycolysis/glycogenolysis within skeletal muscles not tissue hypoperfusion
- Use with caution in pts with CAD
- However clinical trials have not demonstrated worsened outcomes
